By targeting both the Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) receptors, Tirzepatide supports improved blood sugar regulation and appetite control
However, we assume that cost-effectiveness evaluations may vary from one population to another and according to the disease burden, and such findings may differ for the population for whom a combination of GLP-1RAs and SGLT2is is suitable
Bednarek, M
If you or a loved one is experiencing symptoms of a medical emergency, call 911 or seek the nearest emergency room
They will review your health status and weight loss goals to ensure suitability
However, for qualified patients, they may help support appetite control, earlier fullness, reduced food intake, and greater consistency with a medical weight-loss plan